Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for GCR.CX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
March 31, 2026 0.6796M
December 31, 2025 0.8044M
September 30, 2025 0.8425M
June 30, 2025 0.7009M
March 31, 2025 1.287M
December 31, 2024 -23.89M
September 30, 2024 -23.42M
June 30, 2024 -23.63M
March 31, 2024 -23.88M
December 31, 2023 0.5564M
September 30, 2023 -0.2415M
June 30, 2023 0.171M
March 31, 2023 1.334M
December 31, 2022 2.027M
September 30, 2022 0.6659M
June 30, 2022 1.580M
March 31, 2022 2.711M
December 31, 2021 3.674M
September 30, 2021 4.734M
June 30, 2021 5.61M
December 31, 2020 -0.0123M
September 30, 2020 0.0607M
June 30, 2020 0.0683M
March 31, 2020 0.0758M
December 31, 2019 0.0803M
Date Value
September 30, 2019 0.0868M
June 30, 2019 0.09M
March 31, 2019 0.0948M
December 31, 2018 0.0993M
September 30, 2018 -0.0965M
June 30, 2018 -0.0919M
March 31, 2018 -0.0873M
December 31, 2017 -0.1149M
September 30, 2017 -0.1109M
June 30, 2017 -0.1065M
March 31, 2017 -0.1007M
December 31, 2016 -0.0949M
September 30, 2016 -0.0632M
June 30, 2016 -0.0557M
March 31, 2016 -0.0664M
December 31, 2015 -0.0612M
September 30, 2015 -0.0712M
June 30, 2015 -0.063M
March 31, 2015 -0.0532M
December 31, 2014 -0.0464M
September 30, 2014 -0.0352M
June 30, 2014 -0.0242M
March 31, 2014 -0.0073M
December 31, 2013 0.0076M
September 30, 2013 0.0378M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Kane Biotech, Inc. -1.418M
Quest PharmaTech, Inc. 26.43M
BriaCell Therapeutics Corp. 32.75M
Vaxil Bio Ltd. 1.194M
Waverley Pharma, Inc. -2.725M

Shareholders Equity (Quarterly) Related Metrics